Home Podcasts FG Podcast
FG Podcast

FG Podcast

BMJ Group 108 episodes Latest May 20, 2026

The Frontline Gastroenterology (FG) podcast features in-depth interviews with renowned authors and leading experts in gastroenterology, hepatology and clinical nutrition, delving into best practices in the field. It is produced by the BMJ Group and the British Society of Gastroenterology (BSG). The podcast aims to educate and inform healthcare professionals, but does not provide medical advice.

Episodes

Duodenal mucosal ablation and proximal intestinal mucosal ablation May 20, 2026 1756 Discussion of the first systematic review and meta-analysis on duodenal mucosal ablation and discussion of proximal intestinal mucosal ablation, both for the treatment of type 2 diabetes. Links: Proximal intestinal mucosal ablation (PIMA) for the treatment of type 2 diabetes Performance and safety of duodenal mucosal ablation in the management of type 2 diabetes: a systematic review and meta-anal
IBD surveillance - beyond the guidelines Apr 17, 2026 3234 In today's podcast, we discuss a current hot topic in Gastroenterology - IBD surveillance. Join Dr Eathar Shakweh, trainee editor of FG, as she interviews Dr Shahida Din, Dr Ross Porter and Dr Beatriz Gros in discussing a recent publication in the journal, “a real-world retrospective cohort study of IBD colorectal cancer surveillance", alongside real-world challenges, and what the future of IBD ho
The life of an academic in gastroenterology, with Prof. Alexander Ford: Pt 3 Mar 13, 2026 1719 With more than 500 published papers and over 40,000 citations, Prof. Alexander Ford is a notable name in gastroenterology academia. He is a professor of gastroenterology at University of Leeds, honorary consultant gastroenterologist at St. James's University Hospital, Leeds, UK, and the deputy editor of Gut. He joins FG editor Dr. Philip Smith and deputy editor Dr. Aditi Kumar to reflect on his ca
The life of an academic in gastroenterology, with Prof. Alexander Ford: Pt 2 Mar 5, 2026 1795 With more than 500 published papers and over 40,000 citations, Prof. Alexander Ford is a notable name in gastroenterology academia. He is a professor of gastroenterology at University of Leeds, honorary consultant gastroenterologist at St. James's University Hospital, Leeds, UK, and the deputy editor of Gut. He joins FG editor Dr. Philip Smith and deputy editor Dr. Aditi Kumar to reflect on his ca
The life of an academic in gastroenterology, with Prof. Alexander Ford: Pt 1 Feb 24, 2026 1696 With more than 500 published papers and over 40,000 citations, Prof. Alexander Ford is a notable name in gastroenterology academia. He is a professor of gastroenterology at University of Leeds, honorary consultant gastroenterologist at St. James's University Hospital, Leeds, UK, and the deputy editor of Gut. He joins FG editor Dr. Philip Smith and deputy editor Dr. Aditi Kumar to reflect on his ca
Checkpoint inhibitor colitis: a gastroenterologists’ perspective Jan 20, 2026 1851 Frontline Gastroenterology Podcast discussing the recently published paper in the April 2025 edition of the journal Frontline Gastroenterology entitled "Checkpoint inhibitor colitis: a gastroenterologists’ perspective." Dr Ben Zare, FG trainee editor, speaks with Dr Philip Harvey and Dr Aditi Kumar, Consultant Gastroenterologists at The Royal Wolverhampton NHS Trust, Dr Joyce Mak, Consultant at Pr
Functional dyspepsia or gastroparesis? Dec 18, 2025 1881 This Frontline Gastroenterology podcast discusses the FG review entitled 'Functional Dyspepsia or Gastroparesis?' with lead author Prof Daniel Keszthelyi, alongside Dr Dipesh Vasant and Dr Chris Black. From clear definitions and diagnostic pitfalls to what to investigate (and avoid), practical management, and how to communicate the diagnosis—essential listening for gastroenterologists and physicia
Three Critical Months for Patients with Decompensated Alcohol Related Cirrhosis Nov 19, 2025 2085 Deaths from alcohol-related liver disease tragically continue to increase in the United Kingdom. Liver transplant remains a curative option but only to a select cohort, requiring a minimum period of 3 months of abstinence. The group of those who have the highest morbidity and mortality are those admitted due to decompensation and alcohol-related hepatitis, and therefore the first three months po
BASL Special Edition of Frontline Gastroenterology Oct 1, 2025 3088 This special edition has been made to celebrate BASL's affiliation with Frontline Gastroenterology - listen to the team discuss the papers in this recent special edition. Read the issue: https://fg.bmj.com/content/16/e1  Participants: Dr Oliver Tavabie - Deputy Editor at Frontline Gastroenterology and Consultant Hepatologist at the Leeds Liver Unit Dr Louise China - Lead Associate Editor at Frontl
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle Jun 18, 2025 2211 Historically patients with alcohol-related liver disease have received poor quality of care during their admission. In 2014, a guidance bundle was released by the the British Society of Gastroenterology (BSG) and British Association for the Study of the Liver (BASL) to address this issue. This toolkit has recently received an update to incorporate recent advances in care and improve its usability
Role of anti-diabetic medications in the management of MASLD May 28, 2025 1350 The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast. Dr Oliver Tavabie, Deputy Editor at FG and Hepatology Consultant at the Leeds Liver Unit, interviews Drs Scott Isaacs and Paul Brennan. Dr Scott Isaacs is the President of the American Association o
Anti-obesity drugs for the gastroenterologists Apr 23, 2025 1371 This podcast focusses on the Frontline Gastroenterology review paper on anti-obesity medications, authored by Dr Lisa Sharkey. From GLP1-RA GI side effects to nutritional risks, MASLD management and endoscopy considerations — this is a must-listen for every practicing and trainee gastroenterologist navigating the metabolic medicine revolution. Read the manuscript on this link: Anti-obesity drugs f

Recommended

Playing